Cristina Larkin, MBA has more than 30 years of leadership experience in life science companies, serving as COO, CCO, Board Member, and Advisor from pre-clinical through commercial stages. She has helped raise over $400 million in equity and more than $1 billion in business development and non-dilutive capital. Most recently, Cristina was COO/CCO of Spero Therapeutics, a public company focused on rare and infectious diseases.